Dr Thomas Walter
- Specialty
- Oncologist, colon, lung, thyroid expert
- Title
- Head of service
- Hospital
- Hôpital Edouard Herriot (Lyon)
- Latest articles
-
- [(177)Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial. (Jul 2, 2026)
- Deep learning analysis of breast cancer histology predicts ATM pathogenic variant carrier status. (Jun 15, 2026)
- Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217). (Jun 13, 2026)
- Structural and functional mapping of protective human monoclonal antibodies against enterovirus A71. (Jun 5, 2026)
- Neuroendocrine tumours through an epigenetic lens: Emerging insights for diagnosis and treatment. (Jun 1, 2026)